• 7670 W Sahara Ave Suite 2 Las Vegas NV 89117

  • 8779773268

The Bridge Device

The BRIDGE® is a noninvasive, percutaneous electrical nerve field stimulator designed to be placed behind the ear. The NSS-2 Bridge cleared by the FDA, helps patients transition to medication-assisted treatment programs by significantly reducing withdrawal symptoms and begins to work within 30 minutes of placement.

 

 

 

Recovery Solutions That Work.  The FDA Approved Bridge Device

The Bridge Device is a small, FDA cleared electronic device that fits behind the ear and sends electrical feedback to the brain, blocking the pain signals that are associated with withdrawal of opiates during detox. The device can be used for up to 5 days during the acute phase of opioid withdrawal. The physician-placed battery-powered device sits behind the ear and uses three percutaneous electrode arrays and one single-point needle to provide neurostimulation. The Bridge works by applying electrical stimulation the part of the body where addiction starts: the brain. The Bridge targets 4 cranial nerves that are well represented in the auricle. Cranial nerves 5, 7, 9, and 10. These nerves lead back to the brainstem and into the spinal cord to disrupt efferent and afferent pain signals. Studies show that 85% of the symptoms are reduced within 30 minutes by reducing the firing activity in the amygdala, the area of the brain responsible for fear and anxiety.

The Proven Results.  In clinical trials, patients given the Bridge device found that their Clinical Opiate Withdrawal Scale (COWS) scores dropped from the mid 20s to 6 and lower in the first 30 minutes. Prior to the use of the device, the average COWS score for all patients was 20.1. Study results showed that 20 minutes after Bridge device placement, the mean score fell to 7.5 (±5.9) (62.7% reduction; P<0.001). The scores decreased further after 30 minutes to 4.0 (±4.4) and after 60 minutes to 3.1 (±3.4) (84.6% reduction; P<0.001). No additional medications were administered during this period. The mean withdrawal score on day 5, for 33 patients, was 0.6 (97.1% reduction; P<0.001). Overall, 64 of the 73 patients (88%) transitioned to medication-assisted treatment after five days of using the device, along with any medications needed for persisting symptoms, such as nausea and vomiting.

dfa06f25a45fb6771e98e6af50827e7c

Within 20 Minutes symptoms reduced by 67%.
Within 60 Minutes symptoms reduced by 84%.
Overall All Decrease symptoms reduced by 97%.

 

The NSS-2 Bridge is the first device cleared by the FDA for the treatment of symptoms of opioid withdrawal including 

 Pulse Rate & Tremor     

 Sweating & Chills                    

 Anxiety & Restlessness     

 Stomach Cramps & Diarrhea 

 Joint & Muscle Pain      

 Vomiting & Nausea

No surgery is involved with implementing the Bridge detox device. Instead, the Bridge rests behind either ear – so it does interfere with wearing glasses. Electrodes attached to the Bridge are implanted noninvasively to nerve-endings scattered around the auricle (outer ear). Once established, the Bridge device starts sending electrical signals targeting certain areas of the brain implicated in opioid withdrawal and the perception of pain. The device is available by prescription only, and it is contraindicated for patients with hemophilia, patients with cardiac pacemakers and those diagnosed with psoriasis vulgaris, according to the FDA. The Bridge device is not meant to be a single treatment option but a transitional service to an MAT program and counseling.

Ready to find out more about how the Bridge Device can help you?

Drop us a line today for a free quote!